↓ Skip to main content

Dove Medical Press

Article Metrics

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, February 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
1 policy source
twitter
6 tweeters

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
59 Mendeley
Title
“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
Published in
International Journal of Chronic Obstructive Pulmonary Disease, February 2017
DOI 10.2147/copd.s125616
Pubmed ID
Authors

Claus Vogelmeier, Heinrich Worth, Roland Buhl, Carl-Peter Criée, Nadine S Lossi, Claudia Mailänder, Peter Kardos

Abstract

Many patients with chronic obstructive pulmonary disease (COPD) receive inhaled corticosteroids (ICSs) without a clear indication, and thus, the impact of ICS withdrawal on disease control is of great interest. DACCORD is a prospective, noninterventional 2-year study in the primary and secondary care throughout Germany. A subgroup of patients were taking ICS prior to entry - 1,022 patients continued to receive ICS for 2 years; physicians withdrew ICS on entry in 236 patients. Data from these two subgroups were analyzed to evaluate the impact of ICS withdrawal. Patients aged ≥40 years with COPD, initiating or changing COPD maintenance medication were recruited, excluding patients with asthma. Demographic and disease characteristics, prescribed COPD medication, COPD Assessment Test, exacerbations, and lung function were recorded. There were few differences in baseline characteristics; ICS withdrawn patients had shorter disease duration and better lung function, with 74.2% of ICS withdrawn patients not exacerbating, compared with 70.7% ICS-continued patients. During Year 1, exacerbation rates were 0.414 in the withdrawn group and 0.433 in the continued group. COPD Assessment Test total score improved from baseline in both groups. These data suggest that ICS withdrawal is possible with no increased risk of exacerbations in patients with COPD managed in the primary and secondary care.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Other 15 25%
Student > Bachelor 6 10%
Researcher 5 8%
Student > Master 5 8%
Professor 4 7%
Other 15 25%
Unknown 9 15%
Readers by discipline Count As %
Medicine and Dentistry 28 47%
Pharmacology, Toxicology and Pharmaceutical Science 8 14%
Nursing and Health Professions 4 7%
Agricultural and Biological Sciences 3 5%
Computer Science 1 2%
Other 2 3%
Unknown 13 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2018.
All research outputs
#2,673,335
of 12,363,980 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#318
of 1,503 outputs
Outputs of similar age
#83,992
of 334,720 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#23
of 83 outputs
Altmetric has tracked 12,363,980 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,503 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,720 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.